Showing 41 - 50 of 96
Le lymphoedème des membres supérieurs est une complication relativement fréquente après traitement du cancer du sein par chirurgie et/ou radiothérapie. L'incidence en France est de l'ordre de 3740 cas par an avec une prévalence de 37400 cas environ. Le traitement recommandé associe les...
Persistent link: https://www.econbiz.de/10011265527
Background Patent expiries on leading biologics are creating new momentum in the market for biosimilars (copies of off-patent biologics), paving the way for their development. However, little is known about the factors influencing the competition between biosimilars and their reference products...
Persistent link: https://www.econbiz.de/10011228183
Objective: The objective of the study was to compute a cost-effectiveness ratio relating the economic cost of trandolapril to the number of effectiveness units (i.e. life-years) gained. Design and Setting: The trandolapril cardiac evaluation (TRACE) study was a prospective placebo-controlled...
Persistent link: https://www.econbiz.de/10010723167
The availability of the Diagnosis Related Group (DRG) system for determining hospital costs in some European countries has encouraged its use in pharmacoeconomic evaluations. The DRG system was developed in the US to provide data for prospective payments for hospitals. However, the financing of...
Persistent link: https://www.econbiz.de/10010723173
Objective: To assess the relationship between severity and progression of illness in Parkinson's disease and the use of healthcare resources. Design and setting: This was a prospective cost-of-illness study conducted in France based on clinical observation over a 6-month period of patients with...
Persistent link: https://www.econbiz.de/10010723178
Persistent link: https://www.econbiz.de/10010754233
Persistent link: https://www.econbiz.de/10008708701
Persistent link: https://www.econbiz.de/10008235621
Objective: To describe the economic impact of age-related macular degeneration (AMD) and to assess its medical and non-medical costs. Design and settings: An observational study was carried out in 105 patients in two French centres in a sample of 105 French patients. All consecutive patients,...
Persistent link: https://www.econbiz.de/10005449065
The availability of the Diagnosis Related Group (DRG) system for determining hospital costs in some European countries has encouraged its use in pharmacoeconomic evaluations. The DRG system was developed in the US to provide data for prospective payments for hospitals. However, the financing of...
Persistent link: https://www.econbiz.de/10005404858